Travere Therapeutics, Inc. <TVTX.O>: Citigroup Raises Target Price to $85 From $70
TVTX•Related News
InPlay Oil lifts 2026 free adjusted funds flow outlook to CAD 79 million-CAD 89 million
XLE•
Teradata cuts target price to $35.00 from $40.00
TDC•
Holley Q2 FY26 turns to GAAP net loss of $2.4 million; net sales rise 3.2% to $172 million
HLLY•
Certara Inc <CERT.O>: Morgan Stanley cuts target price to $9.00 from $10.00
CERT•
Zeta Global Holdings Corp <ZETA.N>: Morgan Stanley Raises Target Price to $25.00 From $23.00
ZETA•